Appropriate Use Criteria for Nuclear Medicine in the Evaluation and Treatment of Differentiated Thyroid Cancer

J Nucl Med. 2020 Mar;61(3):375-396. doi: 10.2967/jnumed.119.240945.

¹ Society of Nuclear Medicine and Molecular Imaging, Reston, Virginia kdonohoe@caregroup.harvard.edu.
² American Academy of Family Physicians, Washington, DC.
³ American College of Nuclear Medicine, Reston, Virginia.
⁴ European Association of Nuclear Medicine, Vienna, Austria.
⁵ Society of Nuclear Medicine and Molecular Imaging, Reston, Virginia.
⁶ American Thyroid Association, Falls Church, Virginia.
⁷ American Association of Endocrine Surgeons, Lexington, Kentucky.
⁸ American Head and Neck Society, Los Angeles, California.
⁹ American Association of Clinical Endocrinologists, Jacksonsville, Florida; and.
¹⁰ Endocrine Society, Washington, DC.

No abstract available

MeSH terms